Zimmer Biomet Holdings ZBH
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$34.51M (5 inflow days, 15 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 39.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 4.61% to 4.11% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | Hedge Fund | 2026/Q4 | +1,170,000 | 0.6% |
| Freestone Grove Partners LP | Hedge Fund | 2026/Q4 | +1,004,008 | 0.5% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q4 | +851,228 | 1.3% |
| ExodusPoint Capital Management, LP | Hedge Fund | 2026/Q4 | +505,267 | 0.4% |
| Jane Street Group, LLC | Private Company | 2026/Q4 | +394,719 | 0.2% |
| Alberta Investment Management Corporation | Government Pension Fund | 2026/Q4 | +252,106 | 0.3% |
| Amundi Asset Management | Mutual Fund | 2026/Q4 | +213,265 | 0.5% |
| LSV Asset Management | Mutual Fund | 2026/Q4 | +210,992 | 0.2% |
| Invesco Ltd. | Mutual Fund | 2026/Q4 | +196,937 | 0.9% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q4 | +192,423 | 0.4% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q4 | +183,457 | 0.1% |
| Corient Private Wealth LP | Mutual Fund | 2026/Q4 | +167,696 | 0.1% |
| Quantinno Capital Management LP | Mutual Fund | 2026/Q4 | +165,783 | 0.5% |
| JPMorgan Chase & Co. | Public Company | 2026/Q4 | +165,429 | 0.3% |
| PFM Health Sciences, LP | Hedge Fund | 2026/Q4 | +155,425 | 0.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 30 Sep 2026 | Brian Hatcher | President, Recon, S.E.T., CMFT, Neuro and Biosurgery | Initial Statement of Beneficial | +0 | – | 10,425 |
| 30 Sep 2026 | Gary Campbell | President of Americas | Derivative Exercise and Sale | -1,412 | $88.42 | 2,174 |
| 30 Sep 2026 | Gary Campbell | President of Americas | Derivative Exercise and Retained | +2,174 | – | 2,174 |
| 30 Sep 2026 | Gary Campbell | President of Americas | Initial Statement of Beneficial | +0 | – | 8,515 |
| 29 Sep 2026 | Robert Hagemann | Independent Director | Other Derivative Acquisition | +306 | $89.85 | 33,661 |
| 29 Sep 2026 | Arthur Higgins | Independent Director | Other Derivative Acquisition | +306 | $89.85 | 38,077 |
| 29 Sep 2026 | Louis Shapiro | Independent Director | Other Derivative Acquisition | +153 | $89.85 | 3,865 |
| 29 Sep 2026 | Maria Hilado | Independent Director | Other Derivative Acquisition | +375 | $89.85 | 13,392 |
| 29 Sep 2026 | Michael Farrell | Lead Independent Director | Other Derivative Acquisition | +417 | $89.85 | 20,074 |
| 29 Sep 2026 | Devdatt Kurdikar | Independent Director | Other Derivative Acquisition | +173 | $89.85 | 3,171 |
| 29 Sep 2026 | Sreelakshmi Kolli | Independent Director | Other Derivative Acquisition | +173 | $89.85 | 7,034 |
| 10 Sep 2026 | Kevin Thornal | Former Group President of Global Businesses & Americas | Open Market Disposition | -5,691 | $92.95 | – |
| 3 Sep 2026 | Chad Phipps | Senior VP, Chief Legal & Corporate Affairs Officer and Secretary | Open Market Disposition | -3,000 | $98.35 | 65,231 |
| 2 Aug 2026 | Chintan Desai | President Asia Pacific Region | Other Derivative Acquisition | +10,168 | – | 10,168 |
| 31 Jul 2026 | Kevin Thornal | Former Group President of Global Businesses & Americas | Derivative Exercise and Sale | -4,266 | $92.68 | 5,691 |
| 31 Jul 2026 | Kevin Thornal | Former Group President of Global Businesses & Americas | Derivative Exercise and Retained | +5,691 | – | 5,691 |
| 15 Jul 2026 | Suketu Upadhyay | Former CFO and Executive VP of Finance, Operations & Supply Chain | Intent to Sell (Form 144) | -7,668 | $92.86 | – |
| 29 Jun 2026 | Robert Hagemann | Independent Director | Other Derivative Acquisition | +317 | $86.65 | 33,269 |
| 29 Jun 2026 | Arthur Higgins | Independent Director | Other Derivative Acquisition | +317 | $86.65 | 37,675 |
| 29 Jun 2026 | Louis Shapiro | Independent Director | Other Derivative Acquisition | +158 | $86.65 | 3,703 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 7,848,223 | 4.1% | 3.9 |
| 15 Oct 2026 | 7,959,713 | 4.2% | 3.9 |
| 30 Sep 2026 | 9,745,945 | 5.1% | 4.4 |
| 15 Sep 2026 | 8,576,677 | 4.5% | 4.4 |
| 31 Aug 2026 | 8,788,234 | 4.6% | 6.5 |
| 14 Aug 2026 | 8,795,152 | 4.6% | 2.9 |
No comments yet — be the first to weigh in on ZBH.
Sign in to join the discussion.